The aim of our current study is to evaluate the role of GCN5 in IL-6–stimulated PCa, we first determined the expression level of GCN5 after IL-6 treatment, and then the effects of silencing GCN5 on cell invasion, migration and EMT were evaluated. The gene discussed is IL6; the disease is posterior cortical atrophy.